Reuters Health Report: September 2, 2015

Click to View in Browser Wednesday, September 2, 2015 Tests help shed light on autism genetics (Reuters Health) - Advances in genetic testing may eventually allow for more tailored care for people with an autism spectrum disorder (ASD), researchers say. Gilead combo HIV pill matches Truvada efficacy but safer in trial (Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function. Ukraine outbreak brings polio back to Europe, WHO says GENEVA (Reuters) - Two children in southwestern Ukraine have been paralyzed by polio, the first outbreak of the disease in Europe since 2010, the World Health Organization said on Wednesday, in a setback for a global eradication campaign. FDA approves Tesaro's treatment for chemotherapy-induced nausea (Reuters) - The U.S. Food and Drug Administration approved Tesaro Inc's treatment for chemotherapy-induced nausea and vomiting in adults, the company said on Wednesday. Sixty-one infants die at Indian hospital in just two weeks CUTTACK, India (Reuters) - Sixty-one infants have died at an Indian children's hospital in just two weeks, sparking protests and forcing the state government to launch an investigation. Number of California inmates observed for Legionnaires' disease jumps SACRAMENTO, Calif. (Reuters) - The number of inmates being observed for possible infection with Legionnaires' disease at San Quentin State Prison near San Francisco has jumped from 71 to 85, but the number of confirmed diagnoses held steady at six, authorities said Tuesday. Switzerland imposes alcohol limit on cable car operators ZURICH (Reuters) - Switzerland on Wednesday closed a legal loophole that allowed cable car drivers to escape criminal prosecution if caught drunk on the job as the law did not impose an alcohol limit on them. Medical specialists urge more debate on gene-editing technology LONDON (Reuters) - Medical researchers called on Wednesday for detailed, thoughtful debate on future use of new genetic technology that has the potential to create "designer babies". Amgen's bone drug succeeds in late-stage study (Reuters) - Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study. Novartis, Amgen join forces to fight Alzheimer's and migraine LONDON (Reuters) - Novartis and Amgen are joining forces in the hunt for an Alzheimer's treatment, in the latest sign that drugmakers believe an effective therapy for the memory-robbing disease may be within reach. Related Video Obama: world must reach climate deal in Paris 'while we still can' Kerry warns of "climate refugees" A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2015 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook